1. Home >
  2. M&A >
  3. Divestiture >
  4. Germany >
  5. Lantheus Medical Imaging Acquires Life Molecular

M&A Deal Summary

Lantheus Medical Imaging Acquires Life Molecular

On January 13, 2025, Lantheus Medical Imaging acquired life science company Life Molecular from The Life Healthcare Group for 350M USD

Acquisition Highlights
  • This is Lantheus Medical Imaging’s 2nd transaction in the Life Science sector.
  • This is Lantheus Medical Imaging’s largest (disclosed) transaction.
  • This is Lantheus Medical Imaging’s 1st transaction in Germany.

M&A Deal Summary
Date 2025-01-13
Target Life Molecular
Sector Life Science
Buyer(s) Lantheus Medical Imaging
Sellers(s) The Life Healthcare Group
Deal Type Divestiture
Deal Value 350M USD
Advisor(s) Allen Overy Shearman Sterling (A&O Shearman)
Cliffe Dekker Hofmeyr (Legal)

Target

Life Molecular

Berlin, Germany
Life Molecular is a global radiopharmaceutical company offering novel cutting-edge radiopharmaceuticals that improve early detection and characterization of chronic and life-threatening diseases. Life Molecular is based in Berlin.

Search 205,240 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Lantheus Medical Imaging

North Billerica, Massachusetts, United States
Category Company
Founded 1956
Sector Medical Products
Employees612
Revenue 425M USD (2021)
DESCRIPTION

Lantheus Medical Imaging is a supplier of radiopharmaceuticals and contrast agents for nuclear and ultrasound-based cardiovascular diagnostic imaging procedures. Lantheus Medical Imaging was founded in 1956 and is based in North Billerica, Massachusetts.

DEAL STATS #
Overall 4 of 5
Sector (Life Science) 2 of 3
Type (Divestiture) 1 of 1
Country (Germany) 1 of 1
Year (2025) 1 of 2
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-07-15 Meilleur

Dublin, Ohio, United States

Meilleur is a provider of imaging biomarkers for neurological pathologies, associated information technology and related tools to accelerate the development, approval, and adoption of effective therapies to treat neurodegenerative diseases. Meilleur is based in Dublin, Ohio.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-01-28 Evergreen Theragnostics

Springfield, New Jersey, United States

Evergreen Theragnostics is focused on improving the available options for cancer patients using radiopharmaceuticals. The company is engaged in Contract Development and Manufacturing (CDMO) services as well as drug discovery and commercialization of proprietary products. Evergreen Theragnostics was founded in 2019 and is based in Springfield, New Jersey.

Buy $250M

Seller(S) 1

SELLER

The Life Healthcare Group

Illovo, South Africa
Category Company
Sector Healthcare Services
DESCRIPTION

Life Healthcare is one of the largest private hospital operations outside the United States. Its primary business is acute hospital care and comprises one of the widest geographic spreads of acute-care hospitals and same-day surgical centres in South Africa.

DEAL STATS #
Overall 4 of 4
Sector (Life Science) 1 of 1
Type (Divestiture) 3 of 3
Country (Germany) 1 of 1
Year (2025) 1 of 1
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-10-05 Alliance Medical

Warwick, United Kingdom

Alliance Medical provides a range of diagnostic imaging services (including MRI, CT and PET) used in both private and publicly owned hospitals across Europe. Alliance Medical was founded in 1989 and is based in Warwick, United Kingdom.

Sell £910M
Mergr

Product

Company

Legal